Biocon | inves4: Indian Equity Investing

Key Events

Only the most relevant ones. Captured in a simplistic format. Helps to keep a track, gauge the management quality and take an informed investment decision.

Awards and Recognitions (0)

Key Decisions by Management (0)

Promises/ Predictions by Management (0)

Key financial Decisions (0)

Accounting Observations (0)

Regulatory Actions (0)

Legal Cases (0)

Shareholders Activism (0)

Key Employee Resignations/ Hirings (0)

Customer Feedback (0)

Capacity Expansions (0)

Product/ Service Quality (0)

New Business/ Tie-Ups (0)

Discontinued Businesses (0)

Mergers/ Acquisitions (0)

Restructuring (0)

Fund Raises (0)

Shareholding Changes (0)

Employee Feedback (0)

Views by Analysts/ Investors (0)

Share Picks by Veterans (0)

Interesting Facts (0)

Important News (0)

Eris buying Biocon's two non core formulations business units

November 8, 2023

Eris is acquiring Dermatology and Nephrology branded formulations business units of Biocon Biologics (BBL), a subsidiary of Biocon Limited. The transaction is a Slump Sale Revenues of the acquired businesses...

Do you have something important to share about the Company?

0 Comments

Inline Feedbacks

View all comments